Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 6
2004 6
2005 6
2006 2
2007 5
2008 2
2009 2
2010 2
2011 5
2012 4
2013 2
2014 2
2015 3
2016 3
2017 2
2018 1
2019 3
2020 5
2021 1
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation.
Peris I, Romero-Murillo S, Martínez-Balsalobre E, Farrington CC, Arriazu E, Marcotegui N, Jiménez-Muñoz M, Alburquerque-Prieto C, Torres-López A, Fresquet V, Martínez-Climent JA, Mateos MC, Cayuela ML, Narla G, Odero MD, Vicente C. Peris I, et al. Among authors: odero md. Blood. 2023 Mar 2;141(9):1047-1059. doi: 10.1182/blood.2022016466. Blood. 2023. PMID: 36455198 Free PMC article.
Regulation and role of the PP2A-B56 holoenzyme family in cancer.
Peris I, Romero-Murillo S, Vicente C, Narla G, Odero MD. Peris I, et al. Among authors: odero md. Biochim Biophys Acta Rev Cancer. 2023 Sep;1878(5):188953. doi: 10.1016/j.bbcan.2023.188953. Epub 2023 Jul 10. Biochim Biophys Acta Rev Cancer. 2023. PMID: 37437699 Free article. Review.
Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death.
Fresquet V, Garcia-Barchino MJ, Larrayoz M, Celay J, Vicente C, Fernandez-Galilea M, Larrayoz MJ, Calasanz MJ, Panizo C, Junza A, Han J, Prior C, Fortes P, Pio R, Oyarzabal J, Martinez-Baztan A, Paiva B, Moreno-Aliaga MJ, Odero MD, Agirre X, Yanes O, Prosper F, Martinez-Climent JA. Fresquet V, et al. Among authors: odero md. Cancer Discov. 2021 May;11(5):1268-1285. doi: 10.1158/2159-8290.CD-20-1065. Epub 2020 Dec 18. Cancer Discov. 2021. PMID: 33355179
Set Protein Is Involved in FLT3 Membrane Trafficking.
Marcotegui N, Romero-Murillo S, Marco-Sanz J, Peris I, Berrozpe BS, Vicente C, Odero MD, Arriazu E. Marcotegui N, et al. Among authors: odero md. Cancers (Basel). 2023 Apr 10;15(8):2233. doi: 10.3390/cancers15082233. Cancers (Basel). 2023. PMID: 37190162 Free PMC article.
A novel t(7;13)(p12;q33 approximately q34) in AML-M2.
Gerbino E, Tapinassi C, Malazzi O, Micucci C, Calasanz MJ, Beltran-Heredia JM, Gasparini P, Odero MD, Pelicci PG, Belloni E. Gerbino E, et al. Among authors: odero md. Cancer Genet Cytogenet. 2009 Dec;195(2):198-200. doi: 10.1016/j.cancergencyto.2009.08.009. Cancer Genet Cytogenet. 2009. PMID: 19963127 Free article. No abstract available.
Edelfosine lipid nanosystems overcome drug resistance in leukemic cell lines.
Lasa-Saracíbar B, Estella-Hermoso de Mendoza A, Mollinedo F, Odero MD, Blanco-Príeto MJ. Lasa-Saracíbar B, et al. Among authors: odero md. Cancer Lett. 2013 Jul 1;334(2):302-10. doi: 10.1016/j.canlet.2013.01.018. Epub 2013 Jan 23. Cancer Lett. 2013. PMID: 23353057 Free article.
61 results